Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 11/20 | 0.38 |
| ▸ | CETP | P11597 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
| ▸ | ULK1 | O75385 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | ACP1 | P24666 | 1/20 | 0.35 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.35 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.35 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.35 |
| ▸ | SSU72 | Q9NP77 | 1/20 | 0.35 |
| ▸ | TACR3 | P29371 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4971705 | 0.97 | SLC6A9 (0.40) | SLC6A9TACR1CETPKCNH2ULK1 | |
| SCHEMBL4968815 | 0.76 | CETP (0.55) | SLC6A9TACR1CETPKCNH2ULK1 | |
| SCHEMBL14244157 | 0.76 | CETP (0.47) | CETP | |
| SCHEMBL4970220 | 0.72 | CETP (0.43) | SLC6A9TACR1CETPKCNH2CCR2 | |
| SCHEMBL4967551 | 0.72 | CETP (0.43) | SLC6A9TACR1CETPKCNH2CCR2 | |
| SCHEMBL4966775 | 0.72 | CETP (0.43) | SLC6A9TACR1CETPKCNH2CCR2 | |
| SCHEMBL4971054 | 0.72 | SLC6A9 (0.36) | SLC6A9TACR1CETPKCNH2ULK1 | |
| SCHEMBL757360 | 0.71 | CETP (0.69) | CETPKCNH2 | |
| SCHEMBL758409 | 0.71 | CETP (0.69) | CETPKCNH2 | |
| SCHEMBL760204 | 0.71 | CETP (0.69) | CETPKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1954668-A2 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | Brystol-Myers Squibb Company (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007062308-A2 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |